1-4 of 4
Lina Ma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5457: QLH11811, a selective 4th-generation EGFR inhibitor for osimertinib-resistant EGFR-mutant NSCLC

Shansong Zheng, Wei Deng, Qingmei Zheng, Yingying Yang, Na Li, Tan Pang, Xueying Feng, Simon Taylor, Lina Ma, Yaqiong Wu, Ziwei Zhao
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5457.
https://doi.org/10.1158/1538-7445.AM2022-5457
Published: 15 June 2022
View articletitled, Abstract 5457: QLH11811, a selective 4th-generation EGFR inhibitor for osimertinib-resistant EGFR-mutant NSCLC
Journal Articles

Abstract LB041: THOR-707 (SAR444245), a novel not-alpha IL-2 as monotherapy and in combination with pembrolizumab in advanced/metastatic solid tumors: Interim results from HAMMER, an open-label, multicenter phase 1/2 Study

Filip Janku, Raghad Abdul-Karim, Arun Azad, Johanna Bendell, Gerald Falchook, Hui K. Gan, Tira Tan, Judy S. Wang, Cheng Ean CHEE, Lina Ma, Jill Mooney, Neyssa Marina, Giovanni Abbadessa, Marcos Milla, Tarek Meniawy
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): LB041.
https://doi.org/10.1158/1538-7445.AM2021-LB041
Published: 01 July 2021
View articletitled, Abstract LB041: THOR-707 (SAR444245), a novel not-alpha IL-2 as monotherapy and in combination with pembrolizumab in advanced/metastatic solid tumors: Interim results from HAMMER, an open-label, multicenter phase 1/2 Study
Journal Articles

Abstract 3258: THOR-707, a novel not-alpha IL-2, elicits durable pharmacodynamic responses in non-human primates and efficacy as single agent and in combination with anti PD-1 in multiple syngeneic mouse models

Ingrid B. Joseph, Lina Ma, Jerod L. Ptacin, Carolina E. Caffaro, Hans R. Aerni, Kristine M. San Jose, Michael J. Pena, Robert W. Herman, Yelena Pavlova, David B. Chen, Ken Bragstad, Shukuan Li, Jasmine Nguyen, Laura K. Shawver, Lilia K. Koriazova, Marcos E. Milla
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3258.
https://doi.org/10.1158/1538-7445.AM2019-3258
Published: 01 July 2019
View articletitled, Abstract 3258: THOR-707, a novel not-alpha IL-2, elicits durable pharmacodynamic responses in non-human primates and efficacy as single agent and in combination with anti PD-1 in multiple syngeneic mouse models
Journal Articles

Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling

Shuangshuang Zhong, Huijing Yin, Yueling Liao, Feng Yao, Qi Li, Jie Zhang, Huike Jiao, Yongxu Zhao, Dongliang Xu, Shuli Liu, Hongyong Song, Yong Gao, Jingyi Liu, Lina Ma, Zhi Pang, Ruixu Yang, Chengyi Ding, Beibei Sun, Xiaofeng Lin, Xiaofeng Ye, Wenzheng Guo, Baohui Han, Binhua P. Zhou, Y. Eugene Chin, Jiong Deng
Journal: Cancer Research
Cancer Res (2015) 75 (9): 1801–1814.
https://doi.org/10.1158/0008-5472.CAN-14-2005
Published: 30 April 2015
View articletitled, Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling
Open the PDF for Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling in another window
Includes: Supplementary data